Earnings Previews: Levi Strauss and Tilray

For the third quarter of fiscal 2022, analysts are forecasting sales of $1.6 billion, which would be up 8.6% sequentially and by 6.7% year over year. Adjusted EPS of $0.37, up 27.4% sequentially but down 22.9% year over year, are also expected. For the full 2022 fiscal year ending in November, analysts anticipate EPS of $1.54, up 4.4%, on sales of $6.41 billion, up 11.2%.

Levi Strauss stock trades at 10.8 times expected 2022 EPS, 10.1 times estimated 2023 earnings of $1.78 and 8.9 times estimated 2024 earnings of $1.86 per share. The stock’s 52-week trading range is $14.43 to $28.62. The company pays an annual dividend of $0.48 (yield of 3.08%). Total shareholder return for the past year is negative 32.8%.

Tilray

Shares of cannabis grower Tilray Inc. (NASDAQ: TLRY) have dropped by about 57.3% over the past year. While Canadian pot growers continue to wait for the United States to remove marijuana from the nation’s list of dangerous drugs, they have run into problems of oversupply, falling prices and the strong U.S. dollar. Tilray, the largest Canadian firm, with a market cap of around $1.8 billion, has been diversifying by acquiring craft brewers and expanding in international markets. The company reports results first thing Friday morning.

Of 20 analysts covering the stock, 13 have a Hold rating and four rate the shares at Buy. At a share price of $3.00, the upside potential to the median price target of $4.00 is 33.3%. At the high price target of $12.00, the upside potential is 300%.

For Tilray’s first quarter of fiscal 2023, analysts are looking for revenue of $157.78 million, up 2.9% sequentially but down 6.1% year over year. Analysts expect the company to post a loss per share of $0.07, flat sequentially and year over year. For the full fiscal year ending in May, analysts forecast a loss per share of $0.23, compared to last year’s loss per share of $0.31. Full-year sales are expected to rise by 5.6% to $663.57 million.

Tilray is not expected to post a profit in 2023, 2024 or 2025. The company’s sales to enterprise value multiple is 3.2 times in 2023, 2.7 times in 2024 and 2.4 times in 2025. The stock’s 52-week range is $2.65 to $113.95. Tilray does not pay a dividend, and the total return to shareholders last year was negative 72.1%.

Originally posted at 24/7 Wall St.

Sponsored: Find a Qualified Financial Advisor

Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.